Search

Author/Creator Mamot, C.

1. DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B. (June 2017)

Authors:
Davies, A.J.; Barrans, S.; Maishman, T.; Cummin, T.E.; Bentley, M.; Mamot, C.; Novak, U.; Caddy, J.; Hamid, D.; Kazmi‐Stokes, S.H.; Mcmillan, A.; Fields, P.A.; Pocock, C.; Kruger, A.; Collins, G.; Sha, C.; Clipson, A.; Wang, M.; Tooze, R.M.; Care, M.A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC HETEROGENEITY PREDICTS OUTCOME OF DLBCL LYMPHOMA PATIENTS IN THE SAKK 38/07 STUDY COHORT. (12th June 2019)

Authors:
Ceriani, L.; Pirosa, M.; Stathis, A.; Gritti, G.; Ruberto, T.; Bruno, A.; Moccia, A.; Rambaldi, A.; Ferrari, S.; Giovannella, L.; Hayoz, S.; Mazzucchelli, L.; Dirnhofer, S.; Mamot, C.; Zucca, E.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
77
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas. (March 2021)

Authors:
Rogers, S.J.; Datta, N.R.; Puric, E.; Timm, O.; Marder, D.; Khan, S.; Mamot, C.; Knuchel, J.; Siebenhüner, A.; Pestalozzi, B.; Guckenberger, M.; Bodis, S.; Riesterer, O.
Journal:
Clinical and translational radiation oncology
Issue:
Volume 27(2021)
Page Start:
109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗